PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $85,000 | -77.2% | 14,271 | -73.9% | 0.00% | -78.6% |
| Q2 2017 | $372,000 | -26.3% | 54,771 | +2.3% | 0.01% | -26.3% |
| Q1 2017 | $505,000 | +676.9% | 53,540 | +405.0% | 0.02% | +533.3% |
| Q4 2015 | $65,000 | -40.9% | 10,602 | -42.5% | 0.00% | -25.0% |
| Q1 2015 | $110,000 | +26.4% | 18,431 | -13.3% | 0.00% | +100.0% |
| Q1 2014 | $87,000 | -12.1% | 21,262 | +7.5% | 0.00% | -33.3% |
| Q3 2013 | $99,000 | – | 19,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |